Research and Markets: Acute Heart Failure - Pipeline Review, H2 2013: Data & Analysis on Players such as Bayer AG and Novartis AG

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9wtf8k/acute_heart) has announced the addition of the "Acute Heart Failure - Pipeline Review, H2 2013" report to their offering.

Global Markets Direct's, 'Acute Heart Failure - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Heart Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Heart Failure. Acute Heart Failure - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Acute Heart Failure.

- A review of the Acute Heart Failure products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Acute Heart Failure pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

  • Anexon, Inc.
  • Bayer AG
  • Celladon Corporation
  • Lee's Pharmaceutical Holdings Limited
  • Novartis AG
  • PhaseBio Pharmaceuticals, Inc.
  • Trevena, Inc.

For more information visit http://www.researchandmarkets.com/research/9wtf8k/acute_heart

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular